COLORADO SPRINGS, Colo.,
Nov. 20, 2014 /PRNewswire/ -- As part
of its multi-pronged move into Africa, the CEO of Cannabis Science, Inc.
(OTC: CBIS), a U.S. company specializing in global cannabis
formulation-based drug development and consulting, joined a
delegation lead by Melvin Foote,
Founder, President & CEO of the Constituency for Africa (CFA) that met with Congresswoman
Karen D. Bass (D-CA) and other key
stakeholders.
On Tuesday, Cannabis Science President & CEO Raymond C. Dabney and Director & COO
Chad S. Johnson, Esq., joined a
20-person delegation from the CFA that met with Congresswoman
Karen D. Bass (D-CA), ranking member
of the House Subcommittee on Africa, to discuss U.S. - Africa priorities.
The CFA delegation included Melvin
Foote, CFA, Founder, President and CEO; Dr. Roscoe Moore, CFA Interim Chairman and a Special
Senior Advisor to Cannabis Science; Dr. Johnnetta B. Cole, Director of the Smithsonian
National Museum on African Art; Darius
Mans, President of Africare; Mamadou
Beye, Director of International Relations for Chevron;
former U.S. Ambassador to the Republic of the Congo Dr.
Robin R. Sanders; Dr. Monde
Muyangwa, Director of the Africa Program of the Woodrow Wilson
Center; and other key stakeholders.
"The meetings went very well. From HIV to Cancer to the Ebola
virus, it's clear that Africa
should be a focus for the unique cannabinoid therapeutic approaches
that Cannabis Science is working to develop. We're targeting very
serious health issues with success and that's why we're making some
very strategic inroads in the region. We're very pleased with the
reception we're getting, both in Washington and Africa itself," said Mr. Dabney.
Priority issues included the renewal of the African Growth and
Opportunity Act (AGOA); the U.S. response to the Ebola crisis; the
priority of STEM in Africa;
Diaspora engagement; and follow-up to the U.S. - Africa Leaders
Summit.
Melvin Foote stated, "It is
always great to sit down with Congresswoman Karen Bass, who has firmly established herself
as a 'point person' for Africa in
the U.S. Congress. She is on top of the issues, tireless in her
pursuit of rational decisions and very much a team builder. CFA
feels it an honor and duty to support Congresswoman Bass in her
efforts to craft a forward-thinking and responsive agenda for
Africa in the United States."
"I want to congratulate Melvin
Foote, Dr. Roscoe Moore, and
all the members of the delegation for their ongoing leadership and
interest in health and wellness in Africa. Time is of the essence, and their
leadership is essential," added Dabney.
A former Assistant U.S. Surgeon General, Dr. Moore also served
as the principal liaison between the U.S. Department of Health and
Human Services and various Ministries of Health in Africa, focusing on the development of
infrastructure and technical support for the delivery of preventive
and curative health needs. In his role with Cannabis Science, Moore
serves as an advisor on clinical research and how best to focus
company initiatives to address global public health issues.
Mr. Melvin P. Foote is a pioneer
in the field of African Affairs. He has over 35 years of experience
and has worked in over 30 African countries. And he is recognized
as a leading expert on issues related to African policies and
programs. Mr. Foote is also the founder of a dynamic CFA-related
program called the African American Unity Caucus (AAUC). The AAUC
is a broad-based coalition of African-American and African leaders
of Africa-focused organizations
and groups, to promote pan-Africanism and to link Diaspora leaders
in the Western Hemisphere with the African Union (AU), the
coordinating forum of the nations of Africa. Further, Mr. Foote serves as an
advisor to the African Union's Ambassador to Washington and as a consultant to the World
Bank on African Diaspora issues.
"We're very excited to announce that Cannabis Science is
preparing this aggressive move into the African market with
possible acquisitions and clinical initiatives. We're discussing
research centers, furthering health education there, and
establishing ongoing relationships with multiple governments and
non-governmental organizations," concluded Mr. Dabney.
About Cannabis Science, Inc.
Cannabis Science, Inc.,
takes advantage of its unique understanding of metabolic processes
to provide novel treatment approaches to a number of illnesses for
which current treatments and understanding remain unsatisfactory.
Cannabinoids have an extensive history dating back thousands of
years, and currently, there are a growing number of peer-reviewed
scientific publications that document the underlying biochemical
pathways that cannabinoids modulate. The Company works with leading
experts in drug development, medicinal characterization, and
clinical research to develop, produce, and commercialize novel
therapeutic approaches for the treatment for illnesses caused by
infections as well as for age-related illness. Our initial focus is
on skin cancers and neurological conditions.
Forward-Looking Statements
This Press Release
includes forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Act of 1934. A statement containing words such as "anticipate,"
"seek," intend," "believe," "estimate," "expect," "project,"
"plan," or similar phrases may be deemed "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Some or all of the events or results
anticipated by these forward-looking statements may not occur.
Factors that could cause or contribute to such differences include
the future U.S. and global economies, the impact of competition,
and the Company's reliance on existing regulations regarding the
use and development of cannabis-based drugs. Cannabis Science,
Inc., does not undertake any duty nor does it intend to update the
results of these forward-looking statements.
Cannabis Science, Inc.
Raymond C. Dabney, Director,
President & CEO, Co-Founder
raymond@cannabisscience.com
Tel: 1.310.650.3788
Chad S. Johnson, Esq., Director,
COO, & General Counsel
www.cannabisscience.com
info@cannabisscience.com
Tel: 1.888.777.0658
SOURCE Cannabis Science, Inc.